MARIANO JESÚS
PORTA ETESSAM
Profesor asociado de Ciencias de la Salud
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (15)
2023
-
Consensus about monoclonal antibodies in migraine of the Headache Study Group of the Madrid Association of Neurology
Kranion, Vol. 18, Núm. 1, pp. 5-20
-
Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, pp. S37-S52
-
Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine
Neurology and Therapy, Vol. 12, Núm. 4, pp. 1319-1334
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
2022
-
Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain
Patient Preference and Adherence, Vol. 16, pp. 3291-3302
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
-
Impact of the COVID-19 pandemic on the training of Spanish neurology residents
Neurology Perspectives, Vol. 1, Núm. 2, pp. 124-130
-
Incidence, clinical characteristics, risk factors and outcomes of meningoencephalitis in patients with COVID-19
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 8, pp. 1645-1656
-
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry
Journal of the Neurological Sciences, Vol. 423
-
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
Neurologia, Vol. 36, Núm. 8, pp. 611-617
2020
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578